Andy Vandamme

Andy Vandamme is a seasoned professional in the pharmaceutical industry with extensive experience in quality management and clinical trials. Currently serving as Global Product Quality Manager for IMP at argenx since February 2022, responsibilities include oversight of global clinical trials, Early Access Programs, and Externally Sponsored Research. Previous roles include Clinical Trial Project Director at Novitan, where Andy managed the design and construction of a GMP plant and led comparator sourcing. As Corporate QA Manager at Perrigo Company plc, responsibilities encompassed defining corporate QA strategy and conducting GMP audits. Earlier experience at Takeda involved project management in technical transfers and quality assurance activities. Andy holds multiple advanced degrees, including a Master's in Business Economics from Ghent University and a Master's in Industrial Pharmacy from a consortium of universities.